Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome
暂无分享,去创建一个
A. Murray | C. Chapman | B. Lang | Selina Thomsen | P. Maddison | A. Berretta | P. Gozzard | G. Sadalage | P. A. Ambrose | Girija Sadalage
[1] C. Hoogenraad,et al. The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies , 2019, Brain : a journal of neurology.
[2] A. Murray,et al. The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders , 2019, Journal of Neuroimmunology.
[3] J. Wymer,et al. Paraneoplastic Lambert–Eaton Myasthenic Syndrome With Limbic Encephalitis: Clinical Correlation With the Coexistence of Anti-VGCC and Anti-GABAB Receptor Antibodies , 2017, Journal of clinical neuromuscular disease.
[4] Dong Zhou,et al. Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission , 2017, Neurological research.
[5] B. Lang,et al. Long-term survival in paraneoplastic Lambert-Eaton myasthenic syndrome , 2017, Neurology.
[6] C. Klein,et al. P/Q‐ and N‐type calcium‐channel antibodies: Oncological, neurological, and serological accompaniments , 2016, Muscle & nerve.
[7] F. Chiou-Tan,et al. Repetitive nerve stimulation and single‐fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert–Eaton myasthenic syndrome: Review of recent literature , 2015, Muscle & nerve.
[8] C. Chapman,et al. Paraneoplastic neurologic disorders in small cell lung carcinoma , 2015, Neurology.
[9] F. Woermann,et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[10] C. Bien,et al. Conjoint occurrence of GABAB receptor antibodies in Lambert–Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel , 2014, Journal of Neuroimmunology.
[11] C. Klein,et al. Neural Autoantibody Clusters Aid Diagnosis of Cancer , 2014, Clinical Cancer Research.
[12] R. Hubbard,et al. Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit , 2014, PloS one.
[13] Romana Höftberger,et al. Encephalitis and GABAB receptor antibodies , 2013, Neurology.
[14] J. Britton,et al. GABAB receptor autoantibody frequency in service serologic evaluation , 2013, Neurology.
[15] M. Brodie,et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy , 2013, Epilepsia.
[16] E. Benarroch,et al. GABAB receptors , 2012, Neurology.
[17] J. Verschuuren,et al. Lambert–Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies , 2011, The Lancet Neurology.
[18] J. G. van Dijk,et al. Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Dalmau,et al. GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders , 2011, Neurology.
[20] P. Boyle,et al. Clinical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] Jan P van Meerbeeck,et al. Small-cell lung cancer , 1980, The Lancet.
[22] Andrea Murray,et al. Immunobiomarkers in Small Cell Lung Cancer: Potential Early Cancer Signals , 2010, Clinical Cancer Research.
[23] A. Vincent,et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.
[24] J. Robertson,et al. Technical validation of an autoantibody test for lung cancer , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] D. Friedman,et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen , 2010, The Lancet Neurology.
[26] A. Twijnstra,et al. SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] J. Verschuuren,et al. Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Shin J Oh,et al. Electrophysiological diagnostic criteria of Lambert–Eaton myasthenic syndrome , 2005, Muscle & nerve.
[29] M. Benatar,et al. Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line , 2001, Journal of Neuroimmunology.
[30] D. Jäger,et al. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] Jacqueline Palace,et al. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome , 1997, Journal of the Neurological Sciences.
[32] N. Murray,et al. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. , 1988, Brain : a journal of neurology.